Bank of America’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Buy
145,099
+144,574
+27,538% +$304K ﹤0.01% 5113
2025
Q4
$522 Sell
525
-73
-12% -$45 ﹤0.01% 6554
2025
Q3
$298 Sell
598
-2,692
-82% -$1.45K ﹤0.01% 7674
2025
Q2
$1.84K Sell
3,290
-25,583
-89% -$13.7K ﹤0.01% 7444
2025
Q1
$13.7K Sell
28,873
-37,170
-56% -$27.9K ﹤0.01% 7050
2024
Q4
$66.7K Buy
66,043
+34,466
+109% +$46.9K ﹤0.01% 6548
2024
Q3
$54K Buy
31,577
+1,979
+7% +$3.88K ﹤0.01% 6521
2024
Q2
$75.5K Sell
29,598
-12,745
-30% -$40.3K ﹤0.01% 6376
2024
Q1
$177K Sell
42,343
-546
-1% -$2.31K ﹤0.01% 5943
2023
Q4
$142K Buy
42,889
+2,529
+6% +$4.61K ﹤0.01% 6237
2023
Q3
$80.7K Sell
40,360
-12,868
-24% -$34.2K ﹤0.01% 6333
2023
Q2
$168K Sell
53,228
-18,061
-25% -$58.2K ﹤0.01% 5951
2023
Q1
$247K Buy
71,289
+28,533
+67% +$125K ﹤0.01% 5814
2022
Q4
$219K Buy
42,756
+8,684
+25% +$82K ﹤0.01% 5859
2022
Q3
$337K Sell
34,072
-1,944
-5% -$20.5K ﹤0.01% 5661
2022
Q2
$303K Sell
36,016
-9,739
-21% -$95.5K ﹤0.01% 5793
2022
Q1
$575K Buy
45,755
+4,629
+11% +$61.3K ﹤0.01% 5731
2021
Q4
$652K Buy
41,126
+13,343
+48% +$251K ﹤0.01% 5645
2021
Q3
$699K Buy
27,783
+27,773
+277,730% +$752K ﹤0.01% 5377
2021
Q2
$0 Buy
+10
New +$254 ﹤0.01% 7895

Other funds holding IPSC

Bank of America's IPSC Position: Q1 2026 in Review

Bank of America increased its Century Therapeutics (IPSC) stake by 27,538% in Q1 2026, buying an estimated $304K and bringing the position to 145,099 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #5113.

Bank of America first reported a position in IPSC in Q2 2021 and has held it in 20 quarters since. The position peaked at $699K in Q3 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Bank of America held 145,099 shares of Century Therapeutics worth $328K as of Q1 2026.
  • Bank of America bought 144,574 Century Therapeutics shares in Q1 2026, an estimated $304K.
  • Century Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5113 holding.
  • Bank of America first reported a position in Century Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Bank of America's Century Therapeutics position peaked at $699K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.